Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Not applicableLooking for participantsNCT05487846
What this trial is testing

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Who this might be right for
Metastatic Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
Thomas Jefferson University 120
Not applicableLooking for participantsNCT05577689
What this trial is testing

Novel Therapy Target in Metastatic Prostate Cancer

Who this might be right for
Prostate Neoplasms
Fudan University 100
Early research (Phase 1)Study completedNCT00992745
What this trial is testing

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableLooking for participantsNCT05627219
What this trial is testing

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Who this might be right for
Metastatic Prostate CarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8+1 more
Thomas Jefferson University 30
Not applicableStudy completedNCT03871816
What this trial is testing

Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 14,532
Post-approval studies (Phase 4)Looking for participantsNCT07252726
What this trial is testing

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Who this might be right for
Metastatic Breast CancerMetastatic Prostate Cancer
Ottawa Hospital Research Institute 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528
What this trial is testing

PTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
University of Wisconsin, Madison 60
Early research (Phase 1)Ended earlyNCT04528199
What this trial is testing

[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Looking for participantsNCT06842498
What this trial is testing

FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Kyntra Bio 75
Early research (Phase 1)Study completedNCT02655952
What this trial is testing

Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients

Who this might be right for
Metastatic Breast CancerMetastatic Colon CancerMetastatic Prostate Cancer
WntResearch AB 17
Not applicableStudy completedNCT00213694
What this trial is testing

PROSTACOX : Metastatic Prostate Chemotherapy

Who this might be right for
Metastatic Prostate Cancer
University Hospital, Rouen 52
Early research (Phase 1)Study completedNCT05544227
What this trial is testing

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Williams Cancer Foundation 15
Testing effectiveness (Phase 2)WithdrawnNCT00003622
What this trial is testing

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
James Ahlgren
Large-scale testing (Phase 3)WithdrawnNCT05771896
What this trial is testing

Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC

Who this might be right for
Metastatic Prostate Cancer
GenesisCare USA
Testing effectiveness (Phase 2)Study completedNCT00439270
What this trial is testing

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Bristol-Myers Squibb 49
Large-scale testing (Phase 3)Active Not RecruitingNCT05676203
What this trial is testing

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Jena University Hospital 250
Not applicableStudy completedNCT01762241
What this trial is testing

Xbox Kinect Training in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Hospitalsenheden Vest 46
Testing effectiveness (Phase 2)Ended earlyNCT03810105
What this trial is testing

Olaparib and Durvalumab in Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5
Not applicableStudy completedNCT02998242
What this trial is testing

Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer

Who this might be right for
Quality of Life
Sichuan Provincial People's Hospital 40
Next Page